We develop and manufacture scalable bioprocess technologies for the biotechnology and pharmaceutical industries, supporting both Multi-Use and Single-Use strategies. Our portfolio includes bioreactors, tangential flow filtration (TFF) systems, software for process control and monitoring, cell and gene therapy platforms, modular systems, and single-use consumables such as bags and flowkits. Our solutions are designed to facilitate efficient scale-up from laboratory to pilot and commercial production, ensuring robust performance, automation, and adaptability across a wide range of applications from monoclonal antibodies and vaccines to cell therapies, recombinant proteins, enzymes, microbial fermentation, and more.
| Website | https://tecnic.eu |
| Revenue | $7.9 million |
| Employees | 83 (42 on RocketReach) |
| Founded | 2011 |
| Industry | Biotechnology Research |
| Competitors | Siemens, Honeywell, Schneider Electric, Rockwell Automation, OMRON Group, SICK Sensor Intelligence, Cognex Corporation, FANUC Europe, Endress+Hauser Group, BEA Sensors Europe +47 more (view full list) |
Looking for a particular TECNIC employee's phone or email?
The TECNIC annual revenue was $7.9 million in 2026.
Manel Cudinach is the Founder and CEO of TECNIC.
42 people are employed at TECNIC.